Co-funding Institute(s):
National Cancer Institute (NCI)
Implications of the Discovery of MCV on the Etiology, Pathogenesis, and Clinical Management of Merkel Cell Carcinoma
, November 2009
Bethesda or Annapolis, MD
Contact for additional information: Dr. James J. Goedert, NCI 301-435-4724
Description1. Approaches to deal with the rarity of MCC will be identified. 2. Meeting participants will try to reach consensus on research gaps and priorities within three broadly defined disciplines. The intersections of these two types of outcome are likely to result a series of research protocols.